Browse Healthcare news

Synchron Achieves First Successful Human Implantation of Brain Computer Interface
DeciBio Consulting Acquires Emmes Group’s Molecular Diagnostic (MDx) Testing & Oncology Databases
Hitachi: Chaskey Message Authentication Technology Developed for IoT Systems Supporting Key Infrastructure Adopted by ISO/IEC for Lightweight Cryptography

Kao Named to the Dow Jones Sustainability World Index for Sixth Consecutive Year

Kao Corporation (TOKYO: 4452) has been selected for inclusion in the 2019 Dow Jones Sustainability World Index (DJSI World) and Dow Jones Sustainability Asia Pacific Index (DJSI Asia Pacific), among the world’s most renowned socially responsible investment (SRI) indices. This is the si...

Business Wire via QuoteMedia - 2 hours ago

ONGOING SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against BeiGene, Ltd. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 19, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of BeiGene, Ltd. (“BeiGene” or “the Company”) (NASDAQ: BGNE ) for violations ...

ACCESSWIRE IA via QuoteMedia - 3 hours ago

Eisai’s Promotion and Distribution Agreement with Mylan India for Eribulin Second Brand in India

Aiming to Expand Availability of Eribulin to Patients in India with Two Brands Halaven and Teceris TOKYO, Sept 20, 2019 - (JCN Newswire) - Eisai Co., Ltd. has announced that Eisai's subsidiary Eisai Pharmaceuticals India Pvt. Ltd. and Mylan N. V. subsidiary Mylan India have entered into a li...

ACN Newswire via QuoteMedia - 4 hours ago

ImmunoGen: A Long-Term Investment Based On Its ADC Technology

ImmunoGen, Inc. ( IMGN ) failed a phase 3 trial called FORWARD 1 involving lead drug candidate mirvetuximab in platinum-resistant ovarian cancer, but in a subgroup of patients with high folate receptor alpha expression, the drug showed some positive results. The company laid off 75% of its wor...

SeekingAlpha via QuoteMedia - 4 hours ago

Delta 9 Enters into Binding Letter of Intent to Acquire Two Alberta Retail Stores

Delta 9 Enters into Binding Letter of Intent to Acquire Two Alberta Retail Stores Canada NewsWire WINNIPEG, Sept. 19, 2019 WINNIPEG , Sept. 19, 2019 /CNW/ - DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) ("Delta 9" or the "Company"), is pleased to announce that today...

Canada Newswire via QuoteMedia - 4 hours ago

IMPORTANT SEPTEMBER DEADLINE: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 19, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Aclaris Therapeutics, Inc. ("Aclaris" or "the Company") (NASDAQ: ACRS ) for violations of §§...

ACCESSWIRE IA via QuoteMedia - 5 hours ago

More Than 9 in 10 Surgeons Encounter a Needlestick Injury, New Global Survey Finds

LONDON , Sept. 20, 2019 /PRNewswire/ --   81%  believe high quality gloves impact patient outcomes; 92%  agreed high quality gloves improve safety of clinicians; Survey demonstrates importance surgeons place on high quality gloves in protecting against infect...

PR Newswire via QuoteMedia - 5 hours ago

MARKET ACTIVITY

Symbol Last price Change % change
CNT:CCCentury Global Commodities Corporation 0.10 -0.05 -33.333%
TEI:CCToscana Energy Income Corporation 0.02 -0.01 -25%
BYL:CCBaylin Technologies Inc. 2.52 -0.70 -21.739%
TRIL:CCTrillium Therapeutics Inc. 0.45 -0.11 -19.091%
OGD:CCOrbit Garant Drilling Inc. 0.91 -0.17 -15.741%

CHARTING

YOUR ACCOUNT

Sorry, no results

Sorry, no results